This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Signs That Your Trading Will Ruin Your Retirement - May 28, 2020
by Zacks Equity Research
Achieving your retirement goals takes a much different investing approach than regular stock trading, from smartly managing risk to keeping emotions in check.
Easy Investing Secrets to an Early Retirement - May 27, 2020
by Zacks Equity Research
Accomplishing the financial cushion to retire early is a fantasy for most, but bringing that fantasy to reality is not as difficult as it sounds. If you are willing to make some serious lifestyle adjustments, it can be achievable.
Signs That Your Trading Will Ruin Your Retirement - May 19, 2020
by Zacks Equity Research
Achieving your retirement goals takes a much different investing approach than regular stock trading, from smartly managing risk to keeping emotions in check.
Global Medical REIT (GMRE) Q1 FFO Match Estimates
by Zacks Equity Research
Global Medical REIT (GMRE) delivered FFO and revenue surprises of 0.00% and 2.91%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
How Trading Your Own Retirement Can Fleece Your Financial Future - May 01, 2020
by Zacks Equity Research
Achieving your retirement goals takes a much different investing approach than regular stock trading, from smartly managing risk to keeping emotions in check.
Simple Secrets Anyone Can Use to Reach Early Retirement - April 30, 2020
by Zacks Equity Research
Achieving the financial freedom to retire early is a dream for most, but making that dream a reality isn't as tricky as it sounds. If you are willing to make some serious lifestyle changes and sacrifices, it can be possible.
The Zacks Analyst Blog Highlights: Apple, Amazon, Medical Properties Trust, Amcor and Global Medical REIT
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Apple, Amazon, Medical Properties Trust, Amcor and Global Medical REIT
3 Cheap & Safe High-Yield Dividend Stocks Under $20 to Buy Right Now
by Benjamin Rains
Today we dive into 3 cheap stocks trading under $20 a share that also pay a dividend. Plus, the stocks we focused on are relatively immune from the current coronavirus economic downturn...
Top Ranked Income Stocks to Buy for April 9th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, April 9th
Global Medical REIT (GMRE) Q4 FFO and Revenues Beat Estimates
by Zacks Equity Research
Global Medical REIT (GMRE) delivered FFO and revenue surprises of 5.00% and 5.23%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Global Medical REIT (GMRE) Matches Q3 FFO Estimates
by Zacks Equity Research
Global Medical REIT (GMRE) delivered FFO and revenue surprises of 0.00% and 2.91%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Global Medical REIT (GMRE) Q2 FFO Miss Estimates
by Zacks Equity Research
Global Medical REIT (GMRE) delivered FFO and revenue surprises of -5.26% and 0.81%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for June 26th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Global Medical REIT (GMRE) Lags Q1 FFO and Revenue Estimates
by Zacks Equity Research
Global Medical REIT (GMRE) delivered FFO and revenue surprises of -15.00% and -0.78%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Key Factors to Impact Plymouth Industrial (PLYM) Q1 Earnings
by Zacks Equity Research
Plymouth Industrial's (PLYM) Q1 results likely to reflect healthy fundamentals of the industrial real estate market, and benefits from strategic investments and acquisitions.
Senior Housing Properties (SNH) Q1 Earnings: What's in Store?
by Zacks Equity Research
With majority revenues tied to senior housing assets, the ongoing challenges in the industry will weigh on Senior Housing Properties' (SNH) Q1 earnings.
Key Factors to Impact JLL's Performance This Earnings Season
by Zacks Equity Research
Jones Lang LaSalle's (JLL) Q1 results to reflect strength across its global regions and rising trend of outsourcing of real estate needs. Soft leasing volumes and choppy capital market remain woes.
What's in Store for Two Harbors (TWO) This Earnings Season?
by Zacks Equity Research
Unfavorable spread differential will likely escalate Two Harbors Investment's (TWO) cost of funds. Further, dismal U.S. housing activity might result in muted growth in its RMBS portfolio
What's in the Offing for Uniti Group's (UNIT) Q1 Earnings?
by Zacks Equity Research
Uncertain revenues from the master lease agreement with Windstream and large scale dispositions to impact Uniti Group's (UNIT) results in Q1.
Omega Healthcare (OHI) to Post Q1 Earning: What's in Store?
by Zacks Equity Research
Though Omega Healthcare (OHI) will likely record marginal top-line growth in Q1, results may suggest prevailing legal expenses associated with operator workouts and restructurings.
CBRE Group (CBRE) to Post Q1 Earnings: What's in the Cards?
by Zacks Equity Research
CBRE Group (CBRE) will likely gain in Q1 from improving occupier outsourcing business and strategic buyouts.
SBA Communications (SBAC) Q4 Earnings Beat on Revenue Growth
by Zacks Equity Research
Solid performance across all areas of business, including healthy results in both leasing and services businesses, drives SBA Communications' (SBAC) fourth-quarter earnings.
Global Medical REIT (GMRE) Lags Q3 FFO and Revenue Estimates
by Zacks Equity Research
Global Medical REIT (GMRE) delivered FFO and revenue surprises of -13.04% and -2.37%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Global Medical REIT (GMRE) Q2 FFO Meet Estimates
by Zacks Equity Research
Global Medical REIT (GMRE) delivered FFO and revenue surprises of 0.00% and 3.01%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
GMRE or LAMR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
GMRE vs. LAMR: Which Stock Is the Better Value Option?